Research & Education


CITIVA promotes research and education in various fields of science. This enables us to study, develop, and enhance our knowledge about the medicinal applications of cannabis.

Our Flagship Research, Cultivation, and Product Development Center

Our Research, Cultivation and More plantsProduct Development (RCPD) Center  was designed for CITIVA’s primary mission; to produce safe, organic all natural medicines and meet the needs of our growing patient base.

The RCPD Facility leverages several unique strengths to create a distinctly ideal setting for developing cannabis medicines. Using state of the art cultivation technology, extraction machinery, chemical and data analysis we are able to produce standardized medical cannabis products with specific cannabinoid and terpene formulations, with the precision demanded from pharmaceutical products. Our strategic partnership with UWI provides us with the infrastructure and the ability to collaborate with doctors and researches locally and around the world.

 University of the West Indies- Mona File Feb 17, 2 43 46 PM

With our partners at UWI, CITIVA built a large open space greenhouse on the Mona Campus, for the purpose of researching medically beneficial strains of cannabis. Its adjacent laboratory will be used to analyze cannabinoid ratios in extracts, and produce medicines with consistent cannabinoid ratios for our clinical trials. Along with our greenhouse and laboratory, our access to the University’s research hospital provides us with a safe and controlled environment to conduct human trials. With our operational tactics, the experience and expertise of the doctors and researchers at UWI, and massive local support for the project this research facility is slated to become the world leader in cannabinoid medicine.

 

Research into the therapeutic applications of cannabis has been historically inhibited by misguided national and international drug policy. Following the 1961 UN Single Convention on Narcotic Drugs, strict limits and prohibitions on cannabis became accepted international policy. Signatories include almost every nation on earth and are required to implement and enforce laws tightly restricting the use and trade of cannabis. This treaty has made important research into cannabis extraordinarily difficult.

Front of UWIRecently however, attitudes across the globe have shifted. Even the primary international proponent of the cannabis ban, the United States, has seen public support for it wane to a point where large swathes of the country no longer enforce the federal ban. Canada, Mexico, several EU countries, and several South American countries have all recently enacted federally recognized medical cannabis programs.

Even though laws and attitudes are beginning to change research is still difficult even in countries where medical cannabis laws are the most progressive. International bodies and US government programs, which fund a great deal of medical research, will not fund medical cannabis studies except under the narrowest of circumstances. When research is permitted the cost and regulation can be prohibitive.

In 2014, Jamaica’s parliament nearly unanimously passed a cannabis law reform bill. Beside ending the absurd practice of incarcerating people for possession of cannabis, the bill also opened the door for intensive medical cannabis research. Jamaican parliamentarians recognized the proven safety record of cannabis, and changed its classification from a dangerous drug to a natural herbal medicine. Seizing this historic opportunity, with the help of the University of the West Indies, Citiva has established the world’s first dedicated cannabis research, cultivation, and product development facility, within UWI’s medical school.

The RCPD Facility leverages several unique strengths to create a distinctly ideal setting for developing cannabis medicines. Using state of the art cultivation technology, extraction machinery, chemical and data analysis we are able to produce standardized medical cannabis products with specific cannabinoid and terpene formulations, with the precision demanded from pharmaceutical products. Our strategic partnership with UWI provides us with the infrastructure and the ability to collaborate with doctors and researches locally and around the world.

Millions of people have obtained effective relief from painful symptoms through the use of cannabis. With the tiny trickle of research that has been carried out we have learned amazing things about this plant and what it can provide. With a greater understanding of cannabis and its medicinal compounds, millions more could attain the relief they deserve. CITIVA’s RCPD Facility and the dedicated people we collaborate with will remain at the forefront of this important work.

 

Shaping the Future of Cannabinoid Medicine
212-257-3145

Citiva

About Us

Locations

View Our Videos

Benefits

of Cannabinoids
logo
icon
In the

News

icon
View Our

Videos

icon
Meet the

Team